Afzal Muhammad Zeeshan, Gartz Melanie, Klyachko Ekaterina A, Khan Sadiya Sana, Shah Sanjiv J, Gupta Sweta, Shapiro Amy D, Vaughan Douglas E, Strande Jennifer L
Department of Medicine and Cardiovascular Center, Medical College of Wisconsin, Milwaukee, WI, United States.
Department of Medicine, Northwestern University-Feinberg School of Medicine, Chicago, IL, United States.
Stem Cell Res. 2017 Jan;18:33-36. doi: 10.1016/j.scr.2016.12.008. Epub 2016 Dec 9.
We have generated a human induced pluripotent stem cell (iPSC) line under feeder-free culture conditions using the urine derived cells (UCs) collected from non-affected control subjects to use as a comparison group for the iPSC lines containing a Plasminogen Activator Inhibitor-1 (PAI-1 homozygous/heterozygous) mutation. The Sendai Virus (SeV) vector encoding pluripotent Yamanaka transcription factors was used at a low multiplicity of infection to reprogram the UCs.
我们使用从未受影响的对照受试者收集的尿液衍生细胞(UCs),在无饲养层培养条件下生成了一条人类诱导多能干细胞(iPSC)系,用作含有纤溶酶原激活物抑制剂-1(PAI-1纯合/杂合)突变的iPSC系的对照组。编码多能山中转录因子的仙台病毒(SeV)载体以低感染复数用于重编程UCs。